Related Experiment Video
Updated: Apr 11, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by
Cristina El Haj1, Oscar Murillo1, Alba Ribera1
1Laboratory of Experimental Infection, Infectious Diseases Service, IDIBELL, Hospital Universitari de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Abstract:
Whilst levofloxacin (LVX) in combination with rifampicin (RIF) is considered the optimal treatment for prosthetic joint infection (PJI) caused by meticillin-susceptible Staphylococcus aureus (MSSA), no therapeutic alternatives have been accurately evaluated. Based on the high effectiveness of the combination of daptomycin (DAP) plus RIF against meticillin-resistant S. aureus (MRSA) in this setting, in this study the efficacy of DAP+RIF and DAP+LVX combinations was tested as alternative therapies for foreign-body infections (FBIs) caused by MSSA. A tissue-cage infection model was performed using an MSSA strain. Male Wistar rats were treated for 7 days with LVX, DAP, RIF or the combinations LVX+RIF, DAP+RIF and DAP+LVX. Antibiotic efficacy was evaluated by bacterial counts from tissue cage fluid (TCF) and the cure rate was determined from adhered bacteria. Resistance was screened. Monotherapies were less effective than combinations (P<0.05), and resistance to DAP and RIF emerged. DAP+RIF (decrease in bacterial counts in TCF, -4.9logCFU/mL; cure rate, 92%) was the most effective therapy (P<0.05). There were no differences between LVX+RIF (-3.4logCFU/mL; 11%) and DAP+LVX (-3.3logCFU/mL; 47%). No resistant strains appeared with combined therapies. In conclusion, the combinations DAP+RIF and DAP+LVX showed good efficacy and prevented resistance. DAP+RIF provided higher efficacy than LVX+RIF. These DAP combinations were efficacious alternatives therapies for MSSA FBI. Further studies should confirm whether DAP+RIF may be useful as a first-line therapy in the setting of PJI caused by MSSA.
Insights
Daptomycin plus rifampicin (DAP+RIF) and daptomycin plus levofloxacin (DAP+LVX) are effective alternatives for prosthetic joint infections caused by MSSA. DAP+RIF showed superior efficacy and prevented antibiotic resistance.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Prosthetic joint infections (PJI) caused by meticillin-susceptible Staphylococcus aureus (MSSA) typically use levofloxacin (LVX) and rifampicin (RIF).
- Limited therapeutic alternatives exist for MSSA PJI, necessitating evaluation of novel combinations.
- Daptomycin (DAP) has shown efficacy against meticillin-resistant S. aureus (MRSA) PJI, suggesting potential for MSSA treatment.
Purpose of the Study:
- To evaluate the efficacy of daptomycin plus rifampicin (DAP+RIF) and daptomycin plus levofloxacin (DAP+LVX) as alternative therapies for foreign-body infections (FBIs) caused by MSSA.
- To compare the efficacy of these combinations against monotherapies and assess the emergence of antibiotic resistance.
Main Methods:
- A rat tissue-cage infection model using an MSSA strain was employed.
- Animals were treated with monotherapies (LVX, DAP, RIF) or combination therapies (LVX+RIF, DAP+RIF, DAP+LVX) for 7 days.
- Efficacy was assessed by bacterial counts in tissue cage fluid (TCF) and cure rates based on adhered bacteria; resistance screening was performed.
Main Results:
- Combination therapies were significantly more effective than monotherapies (P<0.05).
- DAP+RIF demonstrated the highest efficacy with a -4.9logCFU/mL decrease in bacterial counts and a 92% cure rate.
- DAP+LVX (47% cure rate) and LVX+RIF (11% cure rate) showed varied efficacy, with no resistance emerging in combined therapies.
Conclusions:
- Daptomycin-based combinations, particularly DAP+RIF, are effective alternative therapies for MSSA FBIs, including PJI.
- DAP+RIF exhibited superior efficacy compared to LVX+RIF and prevented the emergence of antibiotic resistance.
- Further research is warranted to explore DAP+RIF as a potential first-line treatment for MSSA PJI.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Inhibitors of Bacterial Protein Synthesis
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

